Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia.

Publication Year: 2022

DOI:
10.3233/CBM-210448

PMCID:
PMC9661315

PMID:
35912731

Journal Information

Full Title: Cancer Biomark

Abbreviation: Cancer Biomark

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This work was funded by the South Wales Gynaecology Cancer Fund and supported by a Cancer Research UK core funding at the Centre for Trials Research, Cardiff University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025